RESEARCH TO ESTABLISH THE FENOFIBRIC ACID STANDARD

Nguyet Suong Huyen Dao1, , Viet Dung Hoang2, Quang Anh Luong3, Hoa Binh Nguyen1, Thi Hien Pham1, THi Kieu Anh Nguyen1, Van Giang Nguyen1, Van Hai Nguyen1, Thi Hai Yen Nguyen4
1 Hanoi University of Pharmacy
2 Hanoi center for Disease Control
3 Le Huu Trac National burn Hospital
4 University of medicine and pharmacy – Vietnam National University, Hanoi

Main Article Content

Abstract

Background: The fenofibric acid standard substance is a mandatory requirement in some analytical methods (such as HPLC, GC, LC_MS/MS) to check the quality of raw materials and finished products containing fenofibric acid, therefore, establishing a secondary standard of fenofibric acid is an urgent requirement in Vietnam. Objectives: To develop basic standards and establish a secondary standard for fenofibric acid which is synthesized in Vietnam. Materials and methods: Fenofibric acid is synthesized by hydrolysis of fenofibrate ester in the basic medium (NaOH) and purified by common methods. Product structure was determined by: IR, MS, 1H-NMR, 13C-NMR, 1H-1H COSY, and XRD. Method for developing quality standards: Evaluation criteria are properties, pH, melting temperature, sulfate ash, weight loss due to drying, identification, impurities, and quantification. Tests are validated according to ICH, ASEAN guidelines, and specialized documents. Standard establishment method: The assigned value of the standard substance is calculated according to the formula: %Content (anhydrous) = Chromatographic purity × (100 - %inorganic impurities - %volatile impurities)/100. Results: Fenofibric acid was synthesized and purified from the hydrolysis reaction of fenofibrate ester with a yield of 96.22% (1.70g). IR, MS, 1HNMR, 13C-NMR, 1H-1H COSY spectra all give signals consistent with the structure of the fenofibric acid molecule; the ultraviolet (UV) spectrum has a maximum absorption peak at 287.98 ± 2 nm. The material has a crystalline structure, with characteristic peaks (d, Å): 15.909; 18.401; 22.539; 23.059 (XRD spectrum). The tests were evaluated, the synthetic material met the established basic standards. The content (anhydrous) of the fenofibric acid secondary standard is 99.4 ± 0.1%. Conclusion: Fenofibric acid after synthesis and purification was used to establish the secondary standard with a labeled (anhydrous) content of 99.4 ± 0.1%.

Article Details

References

1. Grundy S.M., Cleeman J.I., Merz C.N., Brewer H.B., Jr., Clark L.T., et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel
III guidelines. Circulation. 2004, 110(2), 227-239, DOI:
10.1161/01.CIR.0000133317.49796.0E.
2. National Cholesterol Education Program Expert Panel on Detection E., Treatment of High Blood Cholesterol in A. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002, 106(25), 3143-3421, https://pubmed.ncbi.nlm.nih.gov/ 12485966/.
3. Saurav A., Kaushik M., Mohiuddin S.M. Fenofibric acid for hyperlipidemia. Expert Opin Pharmacother. 2012, 13(5), 717-722, DOI: 10.1517/14656566.2012.658774.
4. Abbott Laboratories. Trilipix® (fenofibric acid delayed release capsules). 2011.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=bbf3e782-d163-49c8-0e814eeabef48190.
5. Desager J.P. Gas--liquid chromatographic determination of procetofenic acid in human plasma and urine. Journal of Chromatography. 1978, 145(1), 160-164, DOI:
10.1016/S0378-4347(00)81681-3.
6. Shah I., Barker J., Barton S.J., Naughton D.P. A Novel Method for Determination of Fenofibric Acid in Human Plasma using HPLC-UV: Application to a Pharmacokinetic Study of New Formulations. Journal of Analytical & Bioanalytical Techniques, 2014, DOI:10.4172/2155-9872.S12-009.
7. Wang G, Guo J., Meng F, Song X, Zhong B, Zhao Y. Development of a sensitive liquid chromatography/tandem mass spectrometry method for the determination of fenofibric acid in rat plasma. Biomedical Chromatography. 2012, 26, 497–501, DOI: 10.1002/bmc.1693.
8. United States Pharmacopoeia 44, Software.
9. Bộ Y Tế. Dược điển Việt Nam V. Nhà xuất bản Y học. 2019.
10. ICH harmonised tripartite guideline Q2(R1). Validation of analytical procedures: Text and methodology. 2005. https://www.ema.europa.eu/en/documents/ scientific-guideline/ichguideline-q2r1-validation-analytical-procedures-text-methodology-step-5-first-version.
11. Viện Kiểm nghiệm thuốc Trung ương. Đảm bảo chất lượng thuốc và một số phương pháp kiểm nghiệm thuốc, Nhà xuất bản Y học, Hà Nội. 2010.
12. ASEAN. Asean guidelines for validation and analytical procedures. 2012.
13. United States Pharmacopoeia 46. Validation of compendial procedures. 2023.
14. Streel B., Hubert P., Ceccato A. Determination of fenofibric acid in human plasma using automated solid-phase extraction coupled to liquid chromatography. Journal of Chromatography B: Biomedical Sciences and Applications. 2000, 742(2), 391-400, DOI:
10.1016/s0378-4347(00)00195-x.